| mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.9 |
| mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.0073 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |